New research in mice reveals that aging slows the brain's ability to clear out harmful waste, contributing to neurological disorders like Alzheimer's and Parkinson's. Scientists have found that restoring function in the brain's waste-clearing system, known as the glymphatic system, can reverse these age-related effects. Using a clinically approved drug, researchers increased the efficiency of waste removal, offering a potential treatment strategy for age-related brain diseases.

A new drug, PIPE-307, shows promise in reversing multiple sclerosis (MS) damage by promoting myelin regeneration around nerve cells, potentially restoring movement and function. Developed by researchers, this innovative therapy targets a specific receptor, M1R, and has already demonstrated success in animal models. PIPE-307 is currently in Phase II clinical trials, offering hope for a groundbreaking treatment that could stop and even heal the damage caused by MS. This novel approach could transform the future of MS therapy by addressing both symptoms and underlying damage.

A new study links diets rich in vitamins and minerals, with low added sugar, to younger biological age. Researchers found that healthier diets correlated with a younger epigenetic clock, even accounting for each gram of added sugar. The study is one of the first to show this link in a diverse group of midlife women. Findings highlight the importance of reducing sugar intake for better health and longevity.